Home › AmpliPhi Biosciences' CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International
 

Keywords :   


AmpliPhi Biosciences' CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International

2016-06-01 05:37:22| drugdiscoveryonline Home Page

AmpliPhi Biosciences Corporation , a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, recently announced that M. Scott Salka, AmpliPhi’s Chief Executive Officer, will participate in a panel discussion at this year’s BIO International Convention

Tags: international panel discuss bio

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
16.05Firms leaving UK 'not a crisis' says stock market boss
15.05Exploring the future of agriculture
15.05American, Mexican, and Canadian cattle producers sign joint statement
15.05Attitudes EWG Verified Skincare Line Oceanly Expands with SPF Offerings
15.05Sherwin-Williams Packaging Coatings Expands Non-BPA Coatings Production in Europe
More »